A long term study of cardiovascular outcomes in people with type 2 diabetes.
If you have type 2 Diabetes and cardiovascular disease, you may be eligible to participate in a research study looking at cardiovascular effects of saxagliptin, a diabetes medication.
Who can participate?
- You must have a diagnosis of Type 2 Diabetes
- Men and Women 40 years of age or older
- Your diabetes may be treated with diet and exercise alone or oral medications or insulin or any combination
- You must not be currently taking Onglyza, Januvia, Byetta, or Victoza
Prinicpal Inverstigator: Janet McGill, MD